KUCHARCHUK ANDREW ALBERT 4
4 · CERO THERAPEUTICS HOLDINGS, INC. · Filed Oct 2, 2024
Insider Transaction Report
Form 4
KUCHARCHUK ANDREW ALBERT
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2024-10-01+500,000→ 500,000 totalExercise: $0.10Exp: 2034-09-30→ Common Stock (500,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest in twelve (12) monthly installments following the grant date, subject to the Reporting Person's continued service on each such vesting date.